Lunai Bioworks Inc. (LNAI) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29

Key dataOct 29, 2026

Open$0.23

From 52W high−98.63%

Volume1.28M

Market cap$829677.69

P/E (TTM)—

P/S (TTM)16.0x

Div yield—

Key dataOct 29, 2026

Open

$0.23

From 52W high

−98.63%

Volume

1.28M

Market cap

$829677.69

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

118.1x

P/E (TTM)

—

RSI (14)

13.4

MomentumView details →

1D Return

+0.00%

YTD Return

−97.66%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

118.1x

EV/Sales

−7202.1x

P/S (TTM)

16.0x

P/B (TTM)

−0.1x

ProfitabilityView details →

Gross Margin

−79.88%

Net Margin

−6851.97%

EBITDA Margin

−6097.91%

ROE (TTM)

39.47%

ROA (TTM)

−0.04%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+98.73%

FCF YoY

+32.83%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+98.77%

EBITDA YoY

+98.21%

MomentumView details →

1D Return

+0.00%

YTD Return

−97.66%

1Y Return

−97.81%

RSI (14)

13.4

vs 50D SMA

−89.73%

vs 200D SMA

−94.33%

Capital & dividendView details →

Debt/Equity

−148.30x

Current Ratio

0.11x

Quick Ratio

0.11x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

51992.00

Net Income (TTM)

−3.56M

Op. CF (TTM)

−5.29M

Next earningsNov 12, 2026 →

Latest newsMore news →

Lunai Bioworks Inc. reported that board member Douglas W. Calder resigned, effective October 22, 2026.12d ago

Lunai Bioworks Inc. reported that Chief Financial Officer Nathen Fuentes resigned, effective October 22, 2026.12d ago

Similar companies

IO Biotech, Inc.IOBT NKGen Biotech, Inc. WarrantsNKGNW Voyager Acquisition CorpVRXAW BNB Plus Corp.BNBX Liminatus Pharma, Inc. WarrantsLIMNW Scinai Immunotherapeutics Ltd.SCNI Find similar companies →

Latest newsMore news →

Lunai Bioworks Inc. reported that board member Douglas W. Calder resigned, effective October 22, 2026.12d ago Lunai Bioworks Inc. reported that Chief Financial Officer Nathen Fuentes resigned, effective October 22, 2026.12d ago Lunai Bioworks announced an exclusive worldwide license and collaboration agreement with Tanaist, Inc. to add human cellular phenotyping to its Parkinson's disease discovery and validation platform.43d ago